In vitro evidence for glioblastoma cell death in temperatures found in the penumbra of laser-ablated tumors

References

• Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987–996.
   PubMed Web of Science ®Google Scholar
• Chinot OL, Wick W, Mason W, et al. Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. N Engl J Med. 2014;370(8):709–722.
   PubMed Web of Science ®Google Scholar
• Gilbert MR, Dignam JJ, Armstrong TS, et al. A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med. 2014;370(8):699–708.
   PubMed Web of Science ®Google Scholar
• Omuro A, Vlahovic G, Lim M, et al. Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143. Neuro-oncology. 2018;20(5):674–686.
   PubMed Web of Science ®Google Scholar
• van den Bent M, Eoli M, Sepulveda JM, et al. INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFRamplified glioblastoma. Neuro Oncol. 2019;22(5):684–693.
   Web of Science ®Google Scholar
• Lassman AB, van den Bent MJ, Gan HK, et al. Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with EGFR-amplified, recurrent glioblastoma: results from an international phase I multicenter trial. Neuro Oncol. 2019;21(1):106–114.
   PubMed Web of Science ®Google Scholar
• Bredlau AL, McCrackin MA, Motamarry A, et al. Thermal therapy approaches for treatment of brain tumors in animals and humans. Crit Rev Biomed Eng. 2016;44(6):443–457.
   PubMed Web of Science ®Google Scholar
• Dewhirst MW, Vujaskovic Z, Jones E, et al. Re-setting the biologic rationale for thermal therapy. Int J Hypertherm. 2005;21(8):779–790.
   PubMed Web of Science ®Google Scholar
• Ahmed K, Tabuchi Y, Kondo T. Hyperthermia: an effective strategy to induce apoptosis in cancer cells. Apoptosis. 2015;20(11):1411–1419.
   PubMed Web of Science ®Google Scholar
• Man J, Shoemake JD, Ma T, et al. Hyperthermia sensitizes glioma stem-like cells to radiation by inhibiting AKT signaling. Cancer Res. 2015;75(8):1760–1769.
   PubMed Web of Science ®Google Scholar
• Munier SM, Hargreaves EL, Patel NV, et al. Ablation dynamics of subsequent thermal doses delivered to previously heat-damaged tissue during magnetic resonance-guided laser-induced thermal therapy. J Neurosurg. 2019;131(6):1958–1965.
   Web of Science ®Google Scholar
• Mohammadi AM, Sharma M, Beaumont TL, et al. Upfront magnetic resonance imaging-guided stereotactic laser-ablation in newly diagnosed glioblastoma: a multicenter review of survival outcomes compared to a matched cohort of biopsy-only patients. Neurosurgery. 2019;85(6):762–772.
   PubMed Web of Science ®Google Scholar
• Rahmathulla G, Recinos PF, Kamian K, et al. MRI-guided laser interstitial thermal therapy in neuro-oncology: a review of its current clinical applications. Oncology. 2014;87(2):67–82.
   PubMed Web of Science ®Google Scholar
• Silva D, Sharma M, Juthani R, et al. Magnetic resonance thermometry and laser interstitial thermal therapy for brain tumors. Neurosurg Clin N Am. 2017;28(4):525–533.
   PubMed Web of Science ®Google Scholar
• Voigt JD, Barnett G. The value of using a brain laser interstitial thermal therapy (LITT) system in patients presenting with high grade gliomas where maximal safe resection may not be feasible. Cost Eff Resour Alloc. 2016;14(1):6.
   PubMedGoogle Scholar
• Hafez DM, Liekweg C, Leuthardt EC. Staged laser interstitial thermal therapy (LITT) treatments to left insular low-grade glioma. Neurosurgery. 2020;86(3):E337–E342.
   PubMedGoogle Scholar
• Kamath AA, Friedman DD, Akbari SHA, et al. Glioblastoma treated with magnetic resonance imaging-guided laser interstitial thermal therapy: safety, efficacy, and outcomes. Neurosurgery. 2019;84(4):836–843.
   PubMed Web of Science ®Google Scholar
• Beaumont TL, Mohammadi AM, Kim AH, et al. Magnetic resonance imaging-guided laser interstitial thermal therapy for glioblastoma of the corpus callosum. Neurosurgery. 2018;83(3):556–565.
   PubMed Web of Science ®Google Scholar
• Hawasli AH, Kim AH, Dunn GP, et al. Stereotactic laser ablation of high-grade gliomas. Neurosurg Focus. 2014;37(6):E1.
   PubMed Web of Science ®Google Scholar
• Sharma M, Habboub G, Behbahani M, et al. Thermal injury to corticospinal tracts and postoperative motor deficits after laser interstitial thermal therapy. Neurosurg Focus. 2016;41(4):E6.
   PubMed Web of Science ®Google Scholar
• Lee I, Kalkanis S, Hadjipanayis CG. Stereotactic laser interstitial thermal therapy for recurrent high-grade gliomas. Neurosurgery. 2016;79:S24–S34.
   PubMed Web of Science ®Google Scholar
• Karampelas I, Sloan AE. Laser-induced interstitial thermotherapy of gliomas. Prog Neurol Surg. 2018;32:14–26.
   PubMedGoogle Scholar
• Kim AH, Tatter S, Rao G, et al. Laser ablation of abnormal neurological tissue using robotic neuroblate system (LAANTERN): 12-month outcomes and quality of life after brain tumor ablation. Neurosurgery. 2020. DOI:10.1093/neuros/nyaa071. [Online ahead of print].
   Web of Science ®Google Scholar
• Rennert RC, Khan U, Bartek J, et al. Laser ablation of abnormal neurological tissue using robotic neuroblate system (LAANTERN): procedural safety and hospitalization. Neurosurgery. 2020;86(4):538–547.
   PubMed Web of Science ®Google Scholar
• Morris S-A, Rollo M, Rollo P, et al. Prolonged blood-brain barrier disruption following laser interstitial ablation in epilepsy: a case series with a case report of postablation optic neuritis. World Neurosurg. 2017;104:467–475.
   PubMed Web of Science ®Google Scholar
• Leuthardt EC, Duan C, Kim MJ, et al. Hyperthermic laser ablation of recurrent glioblastoma leads to temporary disruption of the peritumoral blood brain barrier. PLoS One. 2016;11(2):e0148613.
   PubMed Web of Science ®Google Scholar
• Bull JMC. A review of immune therapy in cancer and a question: can thermal therapy increase tumor response? Int J Hyperthermia. 2018;34(6):840–852.
   PubMed Web of Science ®Google Scholar
• He K, Liu P, Xu LX . The cryo-thermal therapy eradicated melanoma in mice by eliciting CD4+ T-cell-mediated antitumor memory immune response. Cell Death Dis. 2017;8(3):e2703.
   PubMed Web of Science ®Google Scholar
• Takaki H, Cornelis F, Kako Y, et al. Thermal ablation and immunomodulation: from preclinical experiments to clinical trials. Diagn Interv Imaging. 2017;98(9):651–659.
   PubMed Web of Science ®Google Scholar
• Hersh DS, Kim AJ, Winkles JA, et al. Emerging applications of therapeutic ultrasound in neuro-oncology: moving beyond tumor ablation. Neurosurgery. 2016;79(5):643–654.
   PubMed Web of Science ®Google Scholar
• Gu ZT, Wang H, Li L, et al. Heat stress induces apoptosis through transcription-independent p53-mediated mitochondrial pathways in human umbilical vein endothelial cell. Sci Rep. 2014;4:4469.
   PubMed Web of Science ®Google Scholar
• Thompson SM, Callstrom MR, Butters KA, et al. Heat stress induced cell death mechanisms in hepatocytes and hepatocellular carcinoma: in vitro and in vivo study. Lasers Surg Med. 2014;46(4):290–301.
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Vitale I, Aaronson SA, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ. 2018;25(3):486–541.
   PubMed Web of Science ®Google Scholar
• Janko C, Munoz L, Chaurio R, et al. Navigation to the graveyard-induction of various pathways of necrosis and their classification by flow cytometry. Methods Mol Biol. 2013;1004:3–15.
   PubMedGoogle Scholar
• Song AS, Najjar AM, Diller KR. Thermally induced apoptosis, necrosis, and heat shock protein expression in 3D culture. J Biomech Eng. 2014;7:136.
   Google Scholar
• Sachet M, Liang YY, Oehler R. The immune response to secondary necrotic cells. Apoptosis. 2017;22(10):1189–1204.
   PubMed Web of Science ®Google Scholar
• Bayin NS, Frenster JD, Kane JR, et al. GPR133 (ADGRD1), an adhesion G-protein-coupled receptor, is necessary for glioblastoma growth. Oncogenesis. 2016;5(10):e263.
   PubMedGoogle Scholar
• Bayin NS, Frenster JD, Sen R, et al. Notch signaling regulates metabolic heterogeneity in glioblastoma stem cells. Oncotarget. 2017;8(39):64932–64953.
   PubMedGoogle Scholar
• Bayin NS, Ma L, Thomas C, et al . Patient-specific screening using high-grade glioma explants to determine potential radiosensitization by a TGF-β small molecule inhibitor. Neoplasia. 2016;18(12):795–805.
   PubMed Web of Science ®Google Scholar
• Feng Y, Tinsley Oden J, Rylander MN. A two-state cell damage model under hyperthermic conditions: theory and in vitro experiments. J Biomech Eng. 2008;130(4):041016.
   PubMed Web of Science ®Google Scholar
• Qin Z, Balasubramanian SK, Wolkers WF, et al. Correlated parameter fit of Arrhenius model for thermal denaturation of proteins and cells. Ann Biomed Eng. 2014;42(12):2392–2404.
   PubMed Web of Science ®Google Scholar
• Rofstad EK, Brustad T. Arrhenius analysis of the heat response in vivo and in vitro of human melanoma xenografts. Int J Hyperthermia. 1986;2(4):359–368.
   PubMedGoogle Scholar
• Toraya-Brown S, Fiering S. Local tumour hyperthermia as immunotherapy for metastatic cancer. Int J Hyperthermia. 2014;30(8):531–539.
   PubMed Web of Science ®Google Scholar
• Toraya-Brown S, Sheen MR, Zhang P, et al. Local hyperthermia treatment of tumors induces CD8(+) T cell-mediated resistance against distal and secondary tumors. Nanomedicine. 2014;10(6):1273–1285.
   PubMed Web of Science ®Google Scholar
• Chen Q, Xu L, Liang C, et al. Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy. Nat Commun. 2016;7:13193.
   PubMed Web of Science ®Google Scholar
• Cloughesy TF, Mochizuki AY, Orpilla JR, et al. Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma. Nat Med. 2019;25(3):477–486.
   PubMed Web of Science ®Google Scholar
• Zhao J, Chen AX, Gartrell RD, et al. Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma. Nat Med. 2019;25(3):462–469.
   PubMed Web of Science ®Google Scholar